Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01436968
Title Phase 3 Study of ProstAtak Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Advantagene, Inc.
Indications

prostate cancer

Therapies

Valacyclovir

AdV-tk + Valacyclovir

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.